Improvement of Libman-Sacks Endocarditis With Combined Hydroxychloroquine-Vitamin K Antagonist Therapy in a Primary Antiphospholipid Syndrome Patient - Université de Rennes Access content directly
Journal Articles Circulation Journal Year : 2018

Improvement of Libman-Sacks Endocarditis With Combined Hydroxychloroquine-Vitamin K Antagonist Therapy in a Primary Antiphospholipid Syndrome Patient

Dates and versions

hal-01879626 , version 1 (24-09-2018)

Identifiers

Cite

Loukman Omarjee, Vincent Jaquinandi, Audrey Camarzana, Frederic Rouleau, Tin-Hinan Mezdad, et al.. Improvement of Libman-Sacks Endocarditis With Combined Hydroxychloroquine-Vitamin K Antagonist Therapy in a Primary Antiphospholipid Syndrome Patient. Circulation Journal, 2018, 82 (9), pp.2380-2382. ⟨10.1253/circj.CJ-17-1131⟩. ⟨hal-01879626⟩
52 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More